Coagulant Therapeutics
Developing Acute Bleeding Solutions
Berkeley, United States · $7.8M raised
- Headquarters
- Berkeley
- Employees
- 1–10
- Business Model
- B2B
- Website
- coagulanttherapeutics.com
- Total Funding
- $7.8M
- Last Round
- $7.8M Venture Round
- Rounds
- 1
About
Coagulant Therapeutics is a Berkeley, California-based clinical-stage biotech developing medicines for acute bleeding, an unmet medical need spanning postpartum hemorrhage, intracranial hemorrhage, and trauma-related bleeding. Its lead program, CT-001, is an engineered short-acting Factor VIIa molecule built on more than 30 patents acquired from Bayer AG and Maxygen, designed to combine potent hemostatic activity with improved safety. Founder and CEO Terry Hermiston leads a team drawing on over 100 years of collective experience in coagulation biology and biologics.
Summary
Coagulant Therapeutics is a Biotech company based in Berkeley, United States. It has raised $7.8M in total across 1 round. Investors include IMM Investment.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/coagulant-therapeutics"><img src="https://indexed.vc/api/badge/company/coagulant-therapeutics" alt="Coagulant Therapeutics on Indexed.vc" width="260" height="76" /></a>